Bronchial asthma, or asthma for short, is a chronic disease of the airway characterised by symptoms such as respiratory distress, chest tightness, wheezing, coughing, sputum formation and exercise intolerance. The asthmatic airway is chronically inflamed due to the activation and/or recruitment of a variety of tissue resident and infiltrating cells including eosinophils, mast cells, T lymphocytes, macrophages, airway epithelial cells (AECs), fibroblasts and airway smooth muscle (ASM) cells. The AEC, which sits at the interface between the host and the external environment, is not only an efficient physical barrier but also represents the first line of defence against microorganisms, airborne irritants and allergens. 1 The airway epithelium maintains the health of the respiratory tract mucosa through its physical barrier function, cilia removal function and natural immune defence function. It plays a central role in the pathogenesis of asthma. On the one hand, changes in its structure and function directly affect the inflammatory response and promote disease formation. On the other hand, the airway epithelium is also significantly damaged by inflammation. At present, the epithelial barrier has been placed in the forefront of the pathophysiology of airway inflammation. Epigenetic studies have confirmed that